Boehringer Ingelheim

Found 2253 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "Boehringer Ingelheim"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Phase 1

Recruiting

Conditions: Healthy

Interventions: Drug: BI 1291583
Drug: erythromycin

First Posted Date: 2025-04-09

Last Posted Date: 2025-05-20

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 16

Registration Number: NCT06917872

Locations: 🇩🇪
CRS Clinical Research Services Berlin GmbH, Berlin, Germany

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men

Phase 1

Recruiting

Conditions: Healthy

Interventions: Drug: BI 3031185
Drug: Midazolam
Drug: Placebo

First Posted Date: 2025-04-08

Last Posted Date: 2025-06-06

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 60

Registration Number: NCT06916702

Locations: 🇩🇪
Charité Research Organisation GmbH, Berlin, Germany

The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

Not yet recruiting

Conditions: Pulmonary Fibrosis

First Posted Date: 2025-04-06

Last Posted Date: 2025-06-11

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 493

Registration Number: NCT06912659

A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: dabigatran etexilate
Drug: BI 1291583

First Posted Date: 2025-03-25

Last Posted Date: 2025-04-02

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 14

Registration Number: NCT06791187

Locations: 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany

Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis

Not yet recruiting

Conditions: Generalized Pustular Psoriasis

Interventions: Drug: Spevigo®

First Posted Date: 2025-03-20

Last Posted Date: 2025-05-28

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 21

Registration Number: NCT06886009

Locations: 🇰🇷
Pusan National University Yangsan Hospital, Busan, Korea, Republic of
🇰🇷
Ajou University Hospital, Gyeonggi-do, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

and more 1 locations

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

Phase 1

Recruiting

Conditions: Colorectal Carcinoma
Gastric Carcinoma
Pancreatic Ductal Adenocarcinoma

Interventions: Drug: BI 765049

First Posted Date: 2025-03-19

Last Posted Date: 2025-05-28

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 135

Registration Number: NCT06882746

Locations: 🇺🇸
Valkyrie Clinical Trials, Los Angeles, California, United States
🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸
Winship Cancer Institute, Atlanta, Georgia, United States

and more 4 locations

A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies

Phase 1

Not yet recruiting

Conditions: Type 1 Interferonopathies

Interventions: Drug: BI 3000202_low dose
Drug: BI 3000202_high dose

First Posted Date: 2025-03-17

Last Posted Date: 2025-06-12

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 18

Registration Number: NCT06878365

Locations: 🇧🇪
UNIV UZ Gent, Gent, Belgium
🇫🇷
HOP Gui de Chauliac, Montpellier, France
🇫🇷
HOP Necker, Paris, France

and more 15 locations

The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Phase 3

Not yet recruiting

Conditions: Bronchiectasis

Interventions: Drug: BI 1291583
Drug: Placebo matching BI 1291583

First Posted Date: 2025-03-12

Last Posted Date: 2025-06-11

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 1680

Registration Number: NCT06872892

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Providence Medical Group Alaska, Anchorage, Alaska, United States
🇺🇸
Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

and more 409 locations

A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: BI 3731579

First Posted Date: 2025-03-06

Last Posted Date: 2025-04-29

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 12

Registration Number: NCT06861829

Locations: 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany

Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)

Phase 1

Completed

Conditions: Diabetes Mellitus Type 2

Interventions: Drug: Empagliflozin + Metformin hydrochloride 12.5 mg/1000 mg combination film-coated tablets
Drug: Synjardy 12.5 mg/1000 mg film-coated tablets

First Posted Date: 2025-02-12

Last Posted Date: 2025-05-23

Lead Sponsor: Gedeon Richter Plc.

Target Recruit Count: 64

Registration Number: NCT06823856

Locations: 🇷🇺
State Budgetary Institution of Healthcare of Yaroslavl region "Yaroslavl Regional Clinical Narcological Hospital, Yaroslavl, Russian Federation

AI-Powered Research

Premium Access

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men

The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body

Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies

The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood

Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)